The molecule that broke the internet's longevity feed
Every so often a single research paper escapes the confines of academia and becomes a cultural event. In June 2023 that paper was about taurine — a humble amino acid most people knew only as an ingredient on the side of an energy-drink can. Overnight, it was recast as a potential elixir. Headlines promised a longer life in a scoop of powder; supplement sales surged; and the longevity influencers, ever hungry for the next lever, moved taurine to the top of their stacks.
The story was irresistible because it was elegant, and because it came with unusually strong pedigree. But the more instructive tale is what happened next — because in 2025 the same molecule became the subject of an equally high-profile reversal. Following taurine from hype to correction is one of the most honest educations available in longevity, and it is exactly the kind of scrutiny the Longevity Royal philosophy is built on.
What taurine actually is
Before the science, the substance. Taurine (chemical formula C2H7NO3S) is a sulphur-containing amino acid — but not one of the twenty that build proteins. Instead it floats free inside cells, most abundantly in the heart, muscle, brain and eyes, where it supports functions as varied as bile-salt formation, the balancing of fluid and minerals within cells, and the calm regulation of the nervous system. The body can synthesise a portion of its own supply, which is why taurine is called “conditionally essential” rather than strictly essential.
The rest comes from the plate. Taurine is concentrated in seafood — scallops, mussels, clams and fish — and in meat, while plant foods contain almost none, which is why the word itself derives from taurus, the Latin for bull, from the ox bile in which it was first identified. This dietary geography matters, and we return to it, because it quietly complicates the neat idea that everyone is running low.
The 2023 promise: an elegant, well-credentialed case
The paper that started it all was published in Science, one of the two most prestigious journals in the world, by Singh, Yadav and a large international consortium.[1] Its central observation was simple and striking: circulating taurine concentrations declined with age in mice, monkeys and humans alike. The team then went further than mere correlation — the hallmark of serious work. When they supplemented middle-aged mice with taurine, the animals lived meaningfully longer, with the authors reporting an increase in median lifespan of around ten to twelve percent. In middle-aged monkeys, six months of supplementation improved a suite of health markers, from bone density to blood-sugar control.
Mechanistically, the paper was equally seductive. Taurine appeared to touch several of the recognised hallmarks of aging at once: it reduced cellular senescence, protected against DNA damage, supported mitochondrial function and dampened the low-grade chronic inflammation researchers call “inflammaging.”[1] Here was a single, cheap, well-tolerated molecule seemingly pulling many of the right levers — and doing so with lifespan data in mammals, a bar most longevity candidates never clear. The authors were careful to call for human trials, but the internet was not listening to the caveats. The verdict had already been written.

The 2025 reversal: when the aging institute checked the work
This is where the story earns its place. In June 2025, a team led by researchers at the US National Institute on Aging — the government body whose entire remit is the biology of aging — published its own analysis in Science, pointedly titled Is taurine an aging biomarker?[2] Their answer was a careful but firm challenge.
The crucial difference was method. The 2023 conclusion leaned heavily on cross-sectional data — comparing different people of different ages at a single moment. The 2025 team instead drew on longitudinal data, following the same individuals over many years, across three geographically distinct human cohorts as well as monkeys and mice. Measured this way, the headline finding did not hold: taurine concentrations generally stayed stable or even increased with age, rather than declining.[2] Just as important, the within-person variation in taurine from one measurement to the next often dwarfed any age-related trend, and its links to health outcomes were inconsistent. Their sober conclusion: a falling taurine level is not a universal feature of aging, and taurine is unlikely to work as a reliable biomarker of it.
It was not an isolated rebuttal. In the same year, a Canadian team publishing in Aging Cell measured taurine in 137 men aged 20 to 93 and found no association between circulating taurine and age, muscle mass, strength, physical performance or mitochondrial function — directly undercutting the idea of taurine deficiency as a primary driver of human aging.[3] Two independent teams, two different methods, the same direction of travel.
How can two Science papers disagree?
To the casual reader this looks like chaos — how can the same journal publish a molecule's coronation and its correction within two years? To the initiated, it looks like science working exactly as designed. A single striking result is a hypothesis, not a verdict; the value of a finding is measured by whether it survives other people trying to break it. The taurine saga is not an embarrassment for the field. It is the immune system of science doing its job in public.
The methodological lesson is worth keeping. Cross-sectional snapshots can mislead: if older generations simply ate differently, or if the frailest individuals with the lowest taurine are the ones who have already passed away, a molecule can appear to “decline with age” when nothing of the sort is happening inside any one person.[4] Following the same people through time is harder, slower and far more trustworthy — and it is precisely the kind of rigour that separates a durable longevity insight from a viral one.
So where does taurine actually stand?
Nowhere near snake oil, and nowhere near proven — which is a perfectly honourable place for a molecule to sit while the science matures. A few points frame it sensibly for anyone building a considered regimen:
- The human aging claim is unproven, not disproven. The 2025 work weakens the “taurine deficiency drives aging” hypothesis in humans; it does not prove taurine is useless. What is missing is the decisive evidence: large, long, randomised human trials measuring real outcomes. Until those report, certainty in either direction is unearned.
- Taurine has other, better-established roles. Independent of the longevity debate, taurine is genuinely important for cardiovascular and metabolic function, and some trials suggest modest benefits for blood pressure and exercise recovery. These are separate questions from whether it extends life.
- Food first, as ever. If you eat seafood and meat, you already consume taurine daily; a strict plant-based diet provides very little, which may make dietary context matter more than a universal deficiency ever did.
- It is well tolerated. Human studies have used roughly 1 to 6 grams a day without serious adverse effects — but “well tolerated” is not the same as “proven to help you age better,” and long-term high-dose safety for that purpose remains unstudied.
The royal verdict
Taurine is a beautiful case study precisely because its story refuses to resolve into a slogan. It arrived wrapped in the credibility of a top journal and mammalian lifespan data, and it was corrected by an institution built to study aging itself — all within twenty-four months. The elegant lesson is not about one amino acid at all. It is that the longevity field advances by contradiction, and that the mark of a discerning approach is the patience to let a claim be tested before it is trusted.
The Longevity Royal position, then, is unhurried. Taurine is worth watching, harmless in sensible amounts, and quietly present in a diet rich in seafood — but it is not, on today's evidence, a proven key to a longer life. Build the foundations that are proven beyond dispute: sleep, movement, protein, sun protection and a diet of real food. Then let the trials come in. Age beautifully by trusting the base, not the trend.
Common questions
Does taurine actually slow aging in humans?
The honest answer in 2026 is: not proven. A high-profile 2023 study in Science reported that taurine declines with age and that supplementation extended lifespan in mice and healthspan in monkeys.[1] But a large 2025 study led by the US National Institute on Aging found that taurine levels actually stayed the same or rose with age when the same individuals were followed over time,[2] and a separate 2025 trial in 137 men found no link between taurine and age or physical performance.[3] Taurine is interesting, but the claim that it slows human aging is currently unproven.
What is taurine and where do you get it?
Taurine (chemical formula C2H7NO3S) is a sulphur-containing amino acid the body can make itself and also obtains from food. It is concentrated in seafood such as scallops, mussels and fish, and in meat, while plant foods contain almost none. It is also the ingredient that gives many energy drinks their name, though the doses studied for aging are far higher than those drinks provide.
Is it safe to take a taurine supplement?
Taurine has a long track record of safety at commonly used doses, and human studies have used 1 to 6 grams per day without serious adverse effects. That said, long-term safety of high doses taken for years specifically for anti-aging has not been established, the aging benefit itself is unproven, and anyone who is pregnant, breastfeeding, or taking medication should consult a doctor before supplementing.
References
Study data sourced via PubMed.
- Singh P, Gollapalli K, Mangiola S, et al. Taurine deficiency as a driver of aging. Science. 2023;380(6649):eabn9257. PubMed · doi:10.1126/science.abn9257
- Fernandez ME, Bernier M, Price NL, et al. Is taurine an aging biomarker? Science. 2025;388(6751):eadl2116. PubMed · doi:10.1126/science.adl2116
- Marcangeli V, Cefis M, Hammad R, et al. Experimental evidence against taurine deficiency as a driver of aging in humans. Aging Cell. 2025;24(10):e70191. PubMed · doi:10.1111/acel.70191
- Acharjee A. Taurine as a biomarker for aging: a new avenue for translational research. Adv Biomark Sci Technol. 2023;5:86–88. PubMed · doi:10.1016/j.abst.2023.10.002